Cesar Trigueros, Chief Scientific Officer Oct. 12 | 10:15am | Ecolab Life Sciences Ballroom San Sebastian, Spain (Private) Viralgen is an independently operated Contract Development and Manufacturing Organization (CDMO), founded in 2017 as a joint venture between AskBio and Columbus Venture Partners (a venture capital firm based in Spain)....
Aileen Fernandes, Chief Business Officer Oct. 11 | 1:45pm | Aseptic Technologies Ballroom Redwood City, CA (NASDAQ: ACLX) Arcellx, Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the...
Evy Lundgren-Åkerlund, CEO Oct. 10 | 5:30pm | Ecolab Life Sciences Ballroom Lund, Sweden (STO: XINT) Xintela is a clinical-stage biopharma company developing allogeneic MSC-based therapies. Xintela’s proprietary product platform XSTEM® consists of homogenous integrin α10β1-selected adipose tissue derived MSCs with superior potency and consistency. XSTEM is manufactured in...
Raj Prabhakar, Chief Business Officer Oct. 11 | 2:00pm | Aseptic Technologies Ballroom Cranbury, NJ (NASDAQ: RCKT) Rocket is a clinical-stage, multi-platform (LVV & AAV) biotechnology company focused on the development of first, only and best-in-class gene therapies, with direct on-target mechanism of action and clear clinical endpoints, for...
Stephen Gunstream, CEO and President Oct. 10 | 3:15pm | Ecolab Life Sciences Ballroom Hollister, California (NASDAQ: TKNO) Teknova makes solutions possible. We help accelerate breakthroughs for customers in bioproduction, molecular diagnostics, and synthetic biology by providing faster access to high-quality, fully customizable agar plates, buffers and reagents, microbial...
Timothy Schroeder, Chairman and CEO Oct. 10 | 4:00pm | Ecolab Life Sciences Ballroom Covington, KY (Private) CTI Clinical Trial and Consulting is a global, privately held, research service organization, delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization....
Uneek Mehra, Chief Financial and Business Officer Oct. 11 | 5:45pm | Aseptic Technologies Ballroom Emeryville, CA (NASDAQ: FDMT) 4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases. 4DMT seeks to unlock the full potential of genetic medicines using...
Fabian Gerlinghaus, CEO Oct. 12 | 11:30am | Ecolab Life Sciences Ballroom South San Francisco, CA (Private) Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies...
Robert Ang, CEO Oct. 10 | 1:45pm | Ecolab Life Sciences Ballroom Cambridge, MA (NASDAQ: VOR) Vor Bio’s novel approach in the fight against cancer: engineer treatment-resistant Hematopoietic Stem Cells (eHSCs) that allow new, potentially curative targeted therapy opportunities post-transplant. We aim to protect the healthy cells and expose...
Stéphane Boissel, CEO Oct. 10 | 2:30pm | Rentschler ATMP Ballroom Paris, France (Private) SparingVision is a clinical-stage genomic medicines company with a mission to translate pioneering science into vision saving treatments. Leveraging its unparalleled understanding of retinal diseases, SparingVision has built the world’s most compelling portfolio of synergistic...
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
October 7-9, 2024
Arizona Biltmore
Phoenix, AZ
